{"transactions":[{"id":3978770,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":65842,"kind":"person","name":"Bell Graeme","position":1,"cik":"0001643757","reported_name":"Bell Graeme","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Stock Option (Right to buy)","published_at":"2018-03-30T14:20:51.000Z","date":"2018-03-28","kind":"exercise","acquired":false,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On January 3, 2017, the Reporting Person was granted an option to purchase 210,000 common shares under the company's 2015 Amended and Restated Stock Option and Incentive Plan. The shares reported as being purchased in this Form 4 were fully vested and exercisable as of the transaction date."}],"balance_after":202000,"derivative":{"exercise_price":13.48,"expiration_date":"2027-01-02","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001209191-18-022178","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000120919118022178/doc4.xml","form_type":"4"}},{"id":3978769,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":65842,"kind":"person","name":"Bell Graeme","position":1,"cik":"0001643757","reported_name":"Bell Graeme","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-03-30T14:20:51.000Z","date":"2018-03-28","kind":"exercise","acquired":true,"shares":8000,"price":13.48,"value":107840.0,"ownership":{"direct":true},"balance_after":21400,"source":{"system":"sec-edgar","filing":"0001209191-18-022178","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000120919118022178/doc4.xml","form_type":"4"}},{"id":4086596,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":65842,"kind":"person","name":"Bell Graeme","position":1,"cik":"0001643757","reported_name":"Bell Graeme","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-01-29T20:31:25.000Z","date":"2018-01-25","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on January 25, 2018 with respect to 25,000 shares of Common Stock, with 25% vesting on January 25, 2019 and the remaining 75% vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":25000,"derivative":{"exercise_price":22.78,"expiration_date":"2028-01-24","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-18-005804","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000120919118005804/doc4.xml","form_type":"4"}},{"id":4131842,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":65842,"kind":"person","name":"Bell Graeme","position":1,"cik":"0001643757","reported_name":"Bell Graeme","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2017-12-14T21:06:41.000Z","date":"2017-12-12","kind":"grant","acquired":true,"shares":72500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on December 12, 2017 with respect to 72,500 shares of Common Stock, with 25% vesting on December 12, 2018 and the remaining 75% vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":72500,"derivative":{"exercise_price":18.295,"expiration_date":"2027-12-11","underlying":"Common Stock","underlying_shares":72500},"source":{"system":"sec-edgar","filing":"0001209191-17-065657","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000120919117065657/doc4.xml","form_type":"4"}},{"id":4172806,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":65842,"kind":"person","name":"Bell Graeme","position":1,"cik":"0001643757","reported_name":"Bell Graeme","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-11-03T15:54:44.000Z","date":"2017-11-03","kind":"grant","acquired":true,"shares":5000,"price":22.0433,"value":110216.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price.  These shares were purchased in multiple transactions at prices ranging from $21.85 to $22.15."}],"balance_after":13400,"source":{"system":"sec-edgar","filing":"0001209191-17-059054","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000120919117059054/doc4.xml","form_type":"4"}},{"id":4293040,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":65842,"kind":"person","name":"Bell Graeme","position":1,"cik":"0001643757","reported_name":"Bell Graeme","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-06-05T11:59:48.000Z","date":"2017-06-02","kind":"grant","acquired":true,"shares":8400,"price":12.3736,"value":103938.24,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.25 to $12.49, inclusive."}],"balance_after":8400,"source":{"system":"sec-edgar","filing":"0001209191-17-037516","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000120919117037516/doc4.xml","form_type":"4"}},{"id":4498743,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":65842,"kind":"person","name":"Bell Graeme","position":1,"cik":"0001643757","reported_name":"Bell Graeme","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2017-01-05T22:57:38.000Z","date":"2017-01-03","kind":"grant","acquired":true,"shares":210000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on January 3, 2017 with respect to 210,000 shares of Common Stock, with 25% vesting on December 12, 2017 and the remaining 75% vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":210000,"derivative":{"exercise_price":13.48,"expiration_date":"2027-01-02","underlying":"Common Stock","underlying_shares":210000},"source":{"system":"sec-edgar","filing":"0001209191-17-002291","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000120919117002291/doc4.xml","form_type":"4"}}]}